AstraZeneca hawks suite of hypertension drugs for $350M in latest asset sale
03 Mar 2020 //
FIERCE PHARMA
After a brief break, AZ is back at divesting handing off hypertension meds $350M
28 Jan 2020 //
ENDPTS
03 Mar 2020 //
FIERCE PHARMA
28 Jan 2020 //
ENDPTS